TrialInvestigational new drugs2017

A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016).

Satoru Miura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.